The Patent Finder
AR

AMS Research Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

24 patents currently held

132 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
36 more records may belong here and await a decision; they are not counted.

The next term ends in May 2027. from the record

Of the 132 now held by other companies, 96 name Boston Scientific Scimed Inc. as their current owner, and 36 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
9
Ending by 2030
May 2027
Next term end
23
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Surgical Needle and Anchor System with Retractable Features US 10,398,431
Cited by 10 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2030.
Ends Aug 2030 · High confidence
Also notable
Implants with Absorbalble and Non-Absorbable Features for the Treatment of Female Pelvic Conditions US 10,492,897
Cited by 15 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2032.
Ends Mar 2032 · High confidence
Also notable
Surgical Articles and Methods for Treating Pelvic Conditions US 10,105,160
Cited by 15 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2027.
Ends May 2027 · High confidence

Formerly held, still cited

Notable
Cited by 132 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2028.
Ends Oct 2028 · High confidence
Also notable
Cited by 59 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Ends Sep 2032 · High confidence
Also notable
Cited by 47 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Ends Aug 2033 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 4, 2026
    The maintenance fee for Biased Artificial Sphincter Cuff (US 10,307,236) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
  • 2 fees due Jan 2 to 21, 2027 · next Jan 2
  • 1 fee due Mar 3, 2027
    The maintenance fee for Surgical Needle and Anchor System with Retractable Features (US 10,398,431) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
  • 2 fees due May 10 to 24, 2027 · next May 10
  • 2 fees due Jun 3 to 10, 2027 · next Jun 3
  • 1 fee due Jul 28, 2027
    The maintenance fee for Passive Artificial Sphincter (US 10,543,074) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
  • 1 fee due Nov 19, 2027
    The maintenance fee for Implants, Tools, and Methods for Treatments of Pelvic Conditions (US 10,653,411) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 11 terms have ended since Aug 22, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,105,160Surgical Articles and Methods for Treating Pelvic Conditions
In force
 · High confidence
In forceHigh confidence
US 9,937,029Surgical Articles and Methods for Treating Pelvic Conditions
In force
 · High confidence
In forceHigh confidence
US 10,034,733Surgical Articles and Methods for Treating Pelvic Conditions
In force
 · High confidence
In forceHigh confidence
US 8,043,204Transobturator Surgical Articles and Methods
In force
 · High confidence
In forceHigh confidence
US 9,192,442Laser Modulation for Coagulation
In force
 · High confidence
In forceHigh confidence
US 10,398,431Surgical Needle and Anchor System with Retractable Features
In force
 · High confidence
In forceHigh confidence
US 9,181,415Acetylated Derivatives of Castor Oil and Their Blends with Epoxidized Fatty Acid Esters
In force
 · Medium confidence
In forceMedium confidence
US 10,307,236Biased Artificial Sphincter Cuff
In force
 · High confidence
In forceHigh confidence
US 9,848,970Patterned Sling Implant and Method
In force
 · High confidence
In forceHigh confidence
US 11,116,618Patterned Sling Implant and Method
In force
 · Medium confidence
In forceMedium confidence
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
Also on record, not counted in the 24: 132 patents in force now held by others · 382 patents ended · 4 applications pending · 192 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited